Assertio Reports Second Quarter 2021 Financial Results
August 05, 2021 16:01 ET
|
Assertio Holdings, Inc.
Reported Net Product Sales of $24.8 Million Raises Full Year Net Product Sales Guidance Range Narrows Previous Non-GAAP Adjusted EBITDA Guidance Range...
Assertio Holdings, Inc. to Report Second Quarter 2021 Financial Results After the Close of Markets on Thursday, August 5, 2021
July 20, 2021 09:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., July 20, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release second quarter 2021 financial results...
Assertio Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement
June 04, 2021 09:27 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., June 04, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that that it received a notification letter from the Listing...
Assertio Holdings, Inc. Announces 1-for-4 Reverse Stock Split
May 17, 2021 06:32 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., May 17, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it has filed a Certificate of Amendment to its...
Assertio Holdings, Inc. Announces Adjournment of Annual Meeting of Shareholders
May 17, 2021 06:30 ET
|
Assertio Holdings, Inc.
- Adjournment Solely to Vote on the Reverse Split and Proportional Authorized Shares Reduction Proposal (Proposal 2) and Increase in Authorized Shares Proposal (Proposal 3) - Both Leading...
Assertio Reports First Quarter 2021 Financial Results
May 06, 2021 16:01 ET
|
Assertio Holdings, Inc.
Reported Net Product Sales of $26.4 Million, Compared to Prior Year Pro-Forma Net Products Sales of $28.3 Million Provides Financial Guidance for 2021 LAKE FOREST, Ill., May 06, 2021 (GLOBE...
Assertio Holdings, Inc. Partners with Cove, a Leading Migraine Telemedicine Platform, To Launch Direct to Patient Digital Campaign to Increase Accessibility of CAMBIA® (diclofenac potassium) and SPRIX® (ketorolac tromethamine)
May 05, 2021 09:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill. and NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or “the Company”) (NASDAQ: ASRT), and Cove, a leading migraine telemedicine platform, today...
Assertio Holdings, Inc. to Report First Quarter 2021 Financial Results After the Close of Markets on Thursday, May 6, 2021
April 22, 2021 09:25 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release first quarter 2021 financial results...
Assertio Reports Fourth Quarter and Full Year 2020 Financial Results
March 11, 2021 16:01 ET
|
Assertio Holdings, Inc.
Full Year Net Product Sales of $93.5 Million; Full Year Pro-Forma Revenue of $119.2 Million in Line with Guidance Post Year-end Raised $45.3 Million in Cash, Net of Expenses, from Closing of...
Assertio Holdings, Inc. to Present at Virtual Roth Conference on Monday, March 15, 2021
March 01, 2021 16:01 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., March 01, 2021 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that Dan Peisert, President and Chief Executive Officer of...